- STAFF PICKS
- GIFTS + GIFT CARDS
- SELL BOOKS
- FIND A STORE
Currently out of stock.
available for shipping or prepaid pickup only
This title in other editions
Other titles in the Contemporary Cardiology series:
Cardiac Drug Therapy (Contemporary Cardiology)by M. Gabriel Khan
Synopses & Reviews
This book addresses the pharmacology and therapeutic application of drugs used to treat heart diseases and hypertension. Additions and updates to the sixth edition include six new chapters on current controversies in cardiac drug therapy such as the beta blocker issue many cardiologists are presently grappling with. The book provides practical advice on how to manage cardiac diseases and addresses the choice of one particular cardiac agent vs. another.
Book News Annotation:
Khan (medicine, U. of Ottawa, and cardiology, The Ottawa Hospital, Ontario, Canada) describes the pharmacology and therapeutic application of drugs used to treat various heart diseases and hypertension. Properties, dosage, action and pharmacokinetics, efficacy, indications, interactions, side effects, potential salutary benefits, and drawbacks are covered. This edition has six new chapters on current controversies in cardiac drug therapy: beta blocker use, ACE inhibitors, calcium antagonists, hypertension, heart failure, and statins. The chapter on hallmark clinical trials has been expanded. The audience for the book includes cardiologists, internists, residents, and general practitioners. Annotation ©2007 Book News, Inc., Portland, OR (booknews.com)
Cardiac Drug Therapy: 7th Edition updates and revises the sixth edition in several respects. The new edition includes six new chapters that deal with ongoing controversies regarding the use of several widely used drugs. These chapters include the betablocker controversies, ACE inhibitor controversies, calcium antagonist controversies, hypertension controversies, heart failure controversies, and Statin controversies.
This new edition continues to be an indispensable, clinical reference. It integrates the basics of cardiovascular therapeutics with practical applications for use. Readers will find in-depth discussions on all major cardiovascular problems, the latest treatment options, and the adverse effects and interactions of the most commonly used cardiovascular drugs.
Table of Contents
CONTENTS 1 Beta-Blockers: The Cornerstone of Cardiac Drug Therapy NEW CONCEPTS BETA-RECEPTORS MECHANISM OF ACTION DOSAGE CONSIDERATIONS PHARMACOLOGIC PROPERTIES AND CLINICAL IMPLICATIONS SALUTARY EFFECTS OF BETA-ADRENERGIC BLOCKADE BETA BLOCKERS VS CALCIUM ANTAGONISTS /NITRATES INDICATIONS FOR BETA-BLOCKERS ADVICE AND ADVERSE EFFECTS INDIVIDUAL BETA BLOCKERS WHICH BETA-BLOCKER TO CHOOSE Please LIST HEADINGS for all chapters 2. Beta blocker Controversies 1 3 Angiotensin-converting Enzyme Inhibitors and Angiotensin II Receptor Blockers 53 Mechanism of Action, 55 ACE Inhibitors Versus Other Vasodilators, 57 Clinical Indications, 59 Contraindications, 64 Advice, Adverse Effects, Interactions, 65 Individual ACE Inhibitors, 67 Angiotensin II Receptor Blockers, 75 4. ACE Inhibitors Controversies 5 Calcium Antagonists (Calcium Channel Blockers) 81 Mechanism of Action, 81 Major Calcium Antagonists, 83 When to Choose a Calcium Antagonist, 93 Indications for Calcium Antagonists in the New Millennium, 94 Which Calcium Antagonist to Choose, 96 Combination of Calcium Antagonists with Beta-Blockers, Nitrates, or Digoxin, 98 6. Calcium Antagonists Controversies 7 Diuretics 103 Indications, 105 Thiazides, 106 Loop Diuretics, 106 Potassium-Sparing Diuretics, 112 Other Diuretics, 117 Potassium Chloride Supplements, 118 Important New Information from Clinical Trials, 123 8 Hypertension new headings to be up dated 127 Relevant Key Issues, 127 Definitions, 130 Nondrug Therapy, 133 Laboratory Work-Up, 134 Which Drugs to Choose, 134 Beta-Blockers, 148 Diuretics, 150 ACE Inhibitors and Angiotensin II Receptor Blockers, 155 Calcium Antagonists (Extended Release), 160 Centrally Acting Drugs, 163 Alpha1-Blockers, 164 Hypertensive Crisis, 166 9 . Hypertension Controversies 10 Management of Angina 179 Salient Clinical Features, 179 Treatment of Stable Angina, 180 Management of Unstable Angina, 194 Variant Angina (Prinzmetal's), 201 Recommendations, 203 11 Management of Acute Myocardial Infarction 209 New Terminology, 209 Therapeutic Implications, 209 Coronary Care Therapeutics, 216 Limitation of Infarct Size and Increased Survival, 221 Thrombolytic Therapy, 222 Beta-Blockers, 233 Nitrates, 235 Ace Inhibitors, 236 Statins, 237 Magnesium, 237 Management of Complications of Infarction, 238 Management of Non-ST-Elevation Myocardial Infarction, 248 12 Management of Heart Failure new headings to add 255 The Size of the Problem, 255 Diagnosis, 258 Basic Cause, 261 Factors Precipitating Heart Failure, 262 Pathophysiology, 263 Vasodilators, 265 Diuretics, 270 Beta-Blockers, 272 Inotropic Agents, 275 Drug Treatment of Systolic Heart Failure, 287 Management of Diastolic Heart Failure, 293 Management of Pulmonary Edema, 294 13. Heart Failure Controversies 14 Management of Cardiac Arrhythmias delete page numbers 301 Classification, 302 Diagnosis of Arrhythmias, 306 Management of Supraventricular Arrhythmias, 309 Ventricular Arrhythmias, 322 Ventricular Tachycardia, 324 Antiarrhythmic Agents, 328 Class IA, 328 Class IB, 333 Class IC, 337 Class II, 340 Class III, 342 15 Cardiac Arrest new headings 353 16 Management of Infective Endocarditis 375 Classification and Diagnosis, 375 Therapy, 381 Prophylaxis of Bacterial Endocarditis, 389 17 Management of Dyslipidemias 397 Diagnosis, 398 NCEP Guidelines, 400 Dietary Therapy, 401 Statins, 408 Combination Therapy, 414 Resins, 415 Nicotinic Acid, 416 Fibrates, 417 Final Statement, 419 18 Statin Controversies 19 Antiplatelet Agents, Anticoagulants, Specific Thrombin Inhibitors 423 Antiplatelet Agents, 423 Anticoagulants, 433 Specific Thrombin Inhibitors, 438 20 Cardiac Drugs During Pregnancy and Lactation 443 Antihypertensive Agents in Pregnancy, 443 Drug Therapy for Heart Failure in Pregnancy, 451 Antiarrhythmic Agents in Pregnancy, 453 Cardiac Drugs During Lactation, 455 21. Effects of Drug Interactions 463 Interactions of Cardiovascular Drugs, 464 Interactions of Cardiac and Noncardiac Drugs, 475 Cardiac Effects of Noncardiac Drugs, 478 22 Hallmark Clinical Trials 487 please fix new headings Acute Coronary Syndrome, RCTs, 488 Heart Failure, RCTs, 496 Cardiovascular Events in High-Risk Patients, 499 Hypertension Trials, 500 Other Hallmark Clinical Trials 505 Appendix I: Infusion Pump Charts Appendix II: Drug Index Index
What Our Readers Are Saying
Health and Self-Help » Health and Medicine » Medical Specialties